Neurological Surgery in Gulfport, MS
3 verified neurological surgery doctors in Gulfport.
Neurosurgeons perform surgery on the brain, spine, and nervous system.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Mississippi State Board of Medical Licensure
Dr. Remi Nader, MD
Neurological Surgery
CMS Open Payments· $5,270 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$5,270
Total received
62
Transactions
6
Paying companies
Top paying companies
Among the 8,465 neurological surgery doctors we've analyzed, about 62% received any industry payment (median $654 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurological surgery doctors.
Payments to Remi Nader do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Eric Wolfson, MD
Neurological Surgery
CMS Open Payments· $35,656 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$35,656
Total received
9
Transactions
4
Paying companies
Top paying companies
Among the 8,465 neurological surgery doctors we've analyzed, about 62% received any industry payment (median $654 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US neurological surgery doctors.
Payments to Eric Wolfson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jhinho Kim, MD
Neurological Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.